Cargando…
The Impact of the COVID-19 Outbreak on Patients’ Adherence to PCSK9 Inhibitors Therapy
PCSK9 inhibitors (PCSK9i) are monoclonal antibodies that have been shown to be effective in reducing both LDL cholesterol (LDL-C) values and major cardiovascular events in patients at high cardiovascular risk. Adherence to PCSK9i is critical for the success of the treatment. The aim of the present s...
Autores principales: | Caso, Valentina Maria, Sperlongano, Simona, Liccardo, Biagio, Romeo, Emanuele, Padula, Sergio, Arenga, Fortunato, D’Andrea, Antonello, Caso, Pio, Golino, Paolo, Nigro, Gerardo, Russo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836402/ https://www.ncbi.nlm.nih.gov/pubmed/35159928 http://dx.doi.org/10.3390/jcm11030475 |
Ejemplares similares
-
Cardiac Back View: An Old Forgotten Echocardiographic Window
por: Carbone, Andreina, et al.
Publicado: (2018) -
Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value
por: Russo, Vincenzo, et al.
Publicado: (2023) -
Left Atrium by Echocardiography in Clinical Practice: From Conventional Methods to New Echocardiographic Techniques
por: Ancona, Roberta, et al.
Publicado: (2014) -
A Systolic Murmur Late after Infective Endocarditis: Looking for the Guilty
por: Sperlongano, Simona, et al.
Publicado: (2019) -
Transcatheter Aortic Valve Implantation: The New Challenges of Cardiac Rehabilitation
por: Sperlongano, Simona, et al.
Publicado: (2021)